Votes: IN SB0221 | 2018 | Regular Session

Bill Title: INSPECT program. Allows a dispenser of ephedrine, pseudoephedrine, or a controlled substance to transmit certain information to the INSPECT program by any electronic method that meets specifications prescribed by the state board of pharmacy (board). Provides that, to the extent considered appropriate by the board, the INSPECT data base must be interoperable with other similar registries operated by federal and state governments. Requires the following practitioners to obtain information about a patient from the data base before prescribing an opioid or benzodiazepine to the patient: (1) A practitioner who has had the information from the data base integrated into the

Spectrum: Slight Partisan Bill (Republican 8-5)

Status: (Passed) 2018-03-22 - Public Law 194 [SB0221 Detail]

Text: Latest bill text (Enrolled) [PDF]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
SenateSenate - Senate concurred in House amendments2018-03-064900150PassedLinkView
HouseHouse - Third reading2018-03-0195005100PassedLinkView
HouseHouse - Committee Vote2018-02-26900413PassedLinkView
SenateSenate - Third reading2018-01-254710149PassedLinkView
SenateSenate - Committee Vote2018-01-171000010PassedLinkView


Social Comments on IN SB0221

feedback